Literature DB >> 25792637

Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patients.

John Z Metcalfe1, Salome Makumbirofa2, Beauty Makamure2, Reggie Mutetwa2, Renée A Peñaloza3, Charles Sandy4, Wilbert Bara5, Stanley Mungofa5, Philip C Hopewell3, Peter Mason6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25792637      PMCID： PMC4948946          DOI： 10.1183/09031936.00214114

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  15 in total

1.  Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.

Authors:  Grant Theron; Jonny Peter; Richard van Zyl-Smit; Hridesh Mishra; Elizabeth Streicher; Samuel Murray; Rodney Dawson; Andrew Whitelaw; Michael Hoelscher; Surendra Sharma; Madhukar Pai; Robin Warren; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

2.  Xpert MTB/RIF false detection of rifampin-resistant tuberculosis from prior infection.

Authors:  J Daniel Kelly; Shou-Yean Grace Lin; Pennan M Barry; Chris Keh; Julie Higashi; John Z Metcalfe
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

3.  Interpreting incremental value of markers added to risk prediction models.

Authors:  Michael J Pencina; Ralph B D'Agostino; Karol M Pencina; A Cecile J W Janssens; Philip Greenland
Journal:  Am J Epidemiol       Date:  2012-08-08       Impact factor: 4.897

4.  Xpert MTB/RIF: monitoring response to tuberculosis treatment.

Authors:  Mark P Nicol
Journal:  Lancet Respir Med       Date:  2013-07-01       Impact factor: 30.700

5.  Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.

Authors:  Sven O Friedrich; Andrea Rachow; Elmar Saathoff; Kasha Singh; Chacha D Mangu; Rodney Dawson; Patrick Pj Phillips; Amour Venter; Anna Bateson; Catharina C Boehme; Norbert Heinrich; Robert D Hunt; Martin J Boeree; Alimuddin Zumla; Timothy D McHugh; Stephen H Gillespie; Andreas H Diacon; Michael Hoelscher
Journal:  Lancet Respir Med       Date:  2013-07-01       Impact factor: 30.700

6.  False-positive Xpert® MTB/RIF assays in previously treated patients: need for caution in interpreting results.

Authors:  T H Boyles; J Hughes; V Cox; R Burton; G Meintjes; M Mendelson
Journal:  Int J Tuberc Lung Dis       Date:  2014-07       Impact factor: 2.373

Review 7.  Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Karen R Steingart; Ian Schiller; David J Horne; Madhukar Pai; Catharina C Boehme; Nandini Dendukuri
Journal:  Cochrane Database Syst Rev       Date:  2014-01-21

8.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

9.  Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis.

Authors:  Andrea Pantoja; Christopher Fitzpatrick; Anna Vassall; Karin Weyer; Katherine Floyd
Journal:  Eur Respir J       Date:  2012-12-20       Impact factor: 16.671

10.  A field evaluation of the Hardy TB MODS Kit™ for the rapid phenotypic diagnosis of tuberculosis and multi-drug resistant tuberculosis.

Authors:  Laura Martin; Jorge Coronel; Dunia Faulx; Melissa Valdez; Mutsumi Metzler; Chris Crudder; Edith Castillo; Luz Caviedes; Louis Grandjean; Mitzi Rodriguez; Jon S Friedland; Robert H Gilman; David A J Moore
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240
View more
  8 in total

1.  False-Positive Xpert MTB/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical Outcomes.

Authors:  Grant Theron; Rouxjeane Venter; Liezel Smith; Aliasgar Esmail; Philippa Randall; Vishesh Sood; Suzette Oelfese; Greg Calligaro; Robin Warren; Keertan Dheda
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

2.  Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?

Authors:  Grant Theron; Rouxjeane Venter; Greg Calligaro; Liezel Smith; Jason Limberis; Richard Meldau; Duncan Chanda; Aliasgar Esmail; Jonny Peter; Keertan Dheda
Journal:  Clin Infect Dis       Date:  2016-02-16       Impact factor: 9.079

3.  Accuracy of a rapid molecular test for tuberculosis in sputum samples, bronchoalveolar lavage fluid, and tracheal aspirate obtained from patients with suspected pulmonary tuberculosis at a tertiary referral hospital.

Authors:  Tatiane Maria da Silva; Valéria Martins Soares; Mariana Gontijo Ramos; Adriana Dos Santos
Journal:  J Bras Pneumol       Date:  2019-03-11       Impact factor: 2.624

4.  Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  David J Horne; Mikashmi Kohli; Jerry S Zifodya; Ian Schiller; Nandini Dendukuri; Deanna Tollefson; Samuel G Schumacher; Eleanor A Ochodo; Madhukar Pai; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2019-06-07

5.  Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.

Authors:  J Z Metcalfe; S Makumbirofa; B Makamure; C Sandy; W Bara; P Mason; P C Hopewell
Journal:  Int J Tuberc Lung Dis       Date:  2016-07       Impact factor: 2.373

6.  Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.

Authors:  Adrienne E Shapiro; Jennifer M Ross; Mandy Yao; Ian Schiller; Mikashmi Kohli; Nandini Dendukuri; Karen R Steingart; David J Horne
Journal:  Cochrane Database Syst Rev       Date:  2021-03-23

7.  The utility of Xpert MTB/RIF performed on bronchial washings obtained in patients with suspected pulmonary tuberculosis in a high prevalence setting.

Authors:  Dewald A Barnard; Elvis M Irusen; Johannes W Bruwer; Danté Plekker; Andrew C Whitelaw; Jacobus D Deetlefs; Coenraad F N Koegelenberg
Journal:  BMC Pulm Med       Date:  2015-09-16       Impact factor: 3.317

8.  Evaluation of Xpert®Mycobacterium tuberculosis/rifampin in sputum-smear negative and sputum-scarce patients with pulmonary tuberculosis using bronchoalveolar lavage fluid.

Authors:  Nikhil C Gowda; Animesh Ray; Manish Soneja; Arjun Khanna; Sanjeev Sinha
Journal:  Lung India       Date:  2018 Jul-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.